{"id":195308,"name":"TAUZIN CONSULTANTS (ON BEHALF OF SCILEX HOLDING COMPANY)","slug":"tauzin-consultants-on-behalf-of-scilex-holding-company","state":"LA","country":"United States of America","description":"Government relations, business development, and business incubation firm.","totalSpending":220000,"filings":14,"yearlySpending":[{"year":2019,"income":60000},{"year":2020,"income":100000},{"year":2021,"income":60000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["TAUZIN STRATEGIC NETWORKS"],"lobbyists":["W.J. TAUZIN"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues related to the opioid crisis","Issues related to combating the opioid epidemic; drug costs; S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act","Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).","Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).","Issues related to the opioid crisis."]}